These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2765186

  • 1. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 2. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH.
    Prog Clin Biol Res; 1985 Aug; 192():131-8. PubMed ID: 4080706
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR, Rotzinger S, Bush DE, DeSousa NJ, Vaccarino FJ.
    Brain Res; 2004 Mar 19; 1001(1-2):95-107. PubMed ID: 14972658
    [Abstract] [Full Text] [Related]

  • 4. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM, Igarashi J, Király I.
    NIDA Res Monogr; 1986 Mar 19; 75():323-6. PubMed ID: 2448632
    [Abstract] [Full Text] [Related]

  • 5. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C, Feldon J.
    Synapse; 1998 Aug 19; 29(4):310-22. PubMed ID: 9661249
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.
    Vaccarino FJ, Vaccarino AL.
    Neurosci Lett; 1989 Feb 13; 97(1-2):151-6. PubMed ID: 2918999
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F, Ettenberg A, Koob GF.
    Psychopharmacology (Berl); 1989 Feb 13; 99(3):409-15. PubMed ID: 2574480
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 Feb 13; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 15. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration.
    Hamilton ME, Redondo JL, Freeman AS.
    Synapse; 2000 Dec 01; 38(3):238-42. PubMed ID: 11020226
    [Abstract] [Full Text] [Related]

  • 16. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR, Melville GN, Wenger T, Louden D.
    West Indian Med J; 1984 Jun 01; 33(2):106-16. PubMed ID: 6541399
    [No Abstract] [Full Text] [Related]

  • 17. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R, Cools AR, Ogren SO.
    Acta Physiol Scand; 1990 Mar 01; 138(3):423-4. PubMed ID: 2158210
    [No Abstract] [Full Text] [Related]

  • 18. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
    Király I, Van Ree JM.
    Neurosci Lett; 1987 Mar 09; 74(3):343-7. PubMed ID: 3561887
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.